In the News
mRNA Vaccine Platforms With Combined Therapeutics’ Dr. Romain Micol
Combined Therapeutics President & CEO Dr. Romain Micol is operating his company in a very noisy space, where hundreds of new biotechs have popped up on the coattails of a COVID-driven renewal of interest in mRNA vaccines. Micol recognizes that noise and the competition it brings for capital and mindshare. He’s not only aware of it — he welcomes it. On this quick episode of the Business of Biotech podcast, Micol shares the unique approach Combined Tx is taking to distinguishing itself in the mRNA infectious disease and cancer vaccine space, from the delivery, safety, efficacy,…
Defining A Competitive Next-Gen RNA Therapeutic In 2024
In the broader advanced therapies space, going from zero to millions of patients in a short period of time is a commercial dynamic we have yet to encounter. Thanks to the myriad scientific and technical hurdles in making cell and gene therapies, we’ve had to start small and incrementally plan for greater access and larger patient populations much farther down the…
News Releases
Combined Therapeutics to Present at 11th International mRNA Health Conference
BOSTON, Oct. 25, 2023 /PRNewswire/ — Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced the participation of Romain Micol, M.D., MPH, Ph.D., President and CEO of Combined Therapeutics, as a speaker at the 11th…
Combined Therapeutics CEO, Romain Micol, to Present at the World Vaccine Congress Europe 2023
BOSTON, Oct. 11, 2023 /PRNewswire/ — Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA vaccines and therapeutics with a novel modified-mRNA platform to treat and prevent infectious diseases and cancer, today announced the participation of Romain Micol, M.D., MPH, Ph.D., President and CEO of Combined Therapeutics, as a speaker at the…
Combined Therapeutics to Present its Next-Generation mRNA-Based Vaccine Platform at the World Vaccine Congress 2023
BOSTON, March 30, 2023 /PRNewswire/ — Combined Therapeutics Inc. (CTx) today announced its participation in the upcoming World Vaccine Congress 2023, taking place in Washington, D.C., April 4-6, where it will present its cutting-edge mRNA-based vaccine technology MOPCTx in a poster presentation and oral…